Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotypeZoltán Bánki, Andreas Aufschnaiter, Janine Kimpel et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 9